Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review

被引:9
作者
Hu, Ruo-Qi [1 ]
Mehter, Hashim [2 ]
Nadasdy, Tibor [3 ]
Satoskar, Anjali [3 ]
Spetie, Dan N. [1 ]
Rovin, Brad H. [1 ]
Hebert, Lee [1 ]
机构
[1] Ohio State Univ, Dept Internal Med, Med Ctr, Div Nephrol, Columbus, OH 43210 USA
[2] Ohio State Univ, Sch Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Med Ctr, Columbus, OH 43210 USA
关键词
oral cyclophosphamide cystitis; cystitis; cyclophosphamide; Wegener's granulomatosis;
D O I
10.1007/s00296-008-0581-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe hemorrhagic cystitis associated with oral cyclophosphamide (CYP) therapy has rarely been reported in the past 20 years, probably because this condition has largely disappeared because of the use of shorter courses of CYP, either oral or IV. Herein, we describe a patient who received 309 g of oral CYP over a 4-year period to treat Wegener's granulomatosis (WG) that initially involved brain, lung, and kidney. She came under our care for the first time when she presented with a one-day history of oliguria and passing blood clots. Severe hemorrhagic cystitis was present. It eventually required cystectomy. Despite her massive CYP exposure her kidney biopsy showed acute crescentic glomerulonephritis. She survived her acute illness only to die 2 months later of acute leukemia. This patient is a reminder that severe hemorrhagic cystitis from oral CYP still exists, and that WG can be resistant to even toxic doses of oral CYP. Alternative therapies are discussed.
引用
收藏
页码:1161 / 1164
页数:4
相关论文
共 21 条
[1]   CYCLOPHOSPHAMIDE AND HEMORRHAGIC CYSTITIS [J].
BENNETT, AH .
JOURNAL OF UROLOGY, 1974, 111 (05) :603-606
[2]   SEVERE CYSTITIS INDUCED BY CYCLOPHOSPHAMIDE - ROLE OF SURGICAL MANAGEMENT [J].
BERKSON, BM ;
LOME, LG ;
SHAPIRO, I .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 225 (06) :605-606
[3]  
Chong KT, 2005, CURR CLIN UROL, P201
[4]   Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis [J].
Christiansen, DH ;
Andersen, MK ;
Pedersen-Bjergaard, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1405-1413
[5]   The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review [J].
de Groot, K ;
Adu, D ;
Savage, COS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (10) :2018-2027
[6]   Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab [J].
Eriksson, P .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (06) :540-548
[7]   Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients [J].
Garderet, L ;
Bittencourt, H ;
Sebe, P ;
Kaliski, A ;
Claisse, JP ;
Espérou, H ;
Ribaud, P ;
Estrade, V ;
Gluckman, E ;
Gattegno, B .
TRANSPLANTATION, 2000, 70 (12) :1807-1811
[8]   Hyperbaric oxygen for cyclophosphamide-induced cystitis [J].
Hughes, MJ ;
Davis, FM ;
Mark, SD ;
Spearing, RL .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) :575-575
[9]  
HUTTER AM, 1969, NEW YORK STATE J MED, V69, P305
[10]   Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis [J].
Klemmer, PJ ;
Chalermskulrat, W ;
Reif, MS ;
Hogan, SL ;
Henke, DC ;
Falk, RJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1149-1153